announced Tuesday that it would test a nasal vaccine for Alzheimer’s disease.The move, the hospital said in a press release, represents the culmination of 20 years of research at the institution."The launch of the first human trial of a nasal vaccine for Alzheimer’s is a remarkable milestone," Dr.
Howard Weiner, co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital, said in a statement.